Shanghai, China, May 19 /Xinhua-PRNewswire-FirstCall/ -- China-Biotics,
Inc. (OTC Bulletin Board: CHBT) (''China-Biotics," "the Company''), a leading
Chinese firm specializing in the manufacture, research, development, marketing
and distribution of probiotics products, today announced it signed a one-year
contract with a subsidiary of Holiland Enterprise Investment Management Co.,
Ltd. (''Holiland'') to supply probiotics for Holiland's bakery products. The
agreement runs through April 2009.
Operating 500 retail stores in China, Holiland is one of the country'best
known national baked food manufacturers and distributors. Hoiland will use a
combination of two Shining Probiotics products, Lactobacillus acidophilus and
Bifidobacterium bifidum (''LA-BB''), in its newly introduced bakery products,
such as probiotics mousse cake and probiotics iced dessert. LA-BB is helpful
in maintaining a balanced gastrointestinal tract. The Holiland product
packaging will include China-Biotics' registered ''Shining Probiotics''
trademark.
''We are pleased to begin this partnership with Holiland, which is one of
the largest suppliers of bakery products in China,'' said Mr. Jinan Song,
China-Biotics' Chairman and Chief Executive Officer. ''This is our second
customer to use our probiotics as a baking ingredient; further broadening our
solid customer base and expanding our target market. We believe our expertise
in the application of probiotics as food additives will continue to attract
more business opportunities in this rapidly growing market. In addition, once
we unveil our new bulk additives plant in 2009, we will be able to widen the
scope of offerings to our customers.''
Economic growth in China exceeded 10% for a fifth consecutive year in 2007
and as the standard of living increases, so does public awareness of health
and dietary issues. Demand for health foods is expected to reach $9.7 billion
by 2010, according to Pacific Bridge Medical. Various applications of
probiotics in daily food, such as dairy products or bakery products, will
benefit consumers' intestinal health.
''Our close working relationship with leading food suppliers in China
creates an innovative health concept which lessens peoples' reliance on
medicine, especially anti-biotics. We are confident with our growth strategy
as a pioneer in the promising new market,'' said Mr. Song.
About Holiland
Established in 1992, Holiland Group is one of the best known national
baked food manufacturers and distributors in China. It owns a number of
factories that comply with HACCP and ISO9000 standards. It has a large
product portfolio that includes cakes, biscuits and pastries. With 500 retail
stores in 50 cities in China, Holiland is one of the best known brands in
China. For more information, please visit http://www.holiland.com.cn .
About China-Biotics, Inc.
Headquartered in Shanghai, China-Biotics, Inc. ("China-Biotics'', ''the
Company'') was founded in 1999 and is one of China's largest suppliers of
probiotics. Probiotics are beneficial live bacteria used as dietary
supplements and food additives to improve intestinal health and digestion.
The Company's product portfolio contains live microbials made with proprietary
technology. Currently, these products are sold over-the-counter under the
''Shining'' brand through large distributors to more than 1,000 pharmacies and
100 supermarkets in Shanghai, Jiangsu and Zhejiang. Shining is one of the
most recognized brands in Shanghai. China-Biotics plans to expand its retail
sales to other major cities in China and is launching 300 Shining brand
logistic centers in these cities. The Company's flagship product, ''Shining
Essence'', has been a profit driver since its launch in April 2001. There is
a significant demand for probiotics for use in the bulk additive market, which
is currently met by imports. China-Biotics is building a new plant which will
increase its production capacity manifolds to capture this market. For more
information, please visit http://www.chn-biotics.com .
Safe Harbor Statement Under the Private Securities Litigation Reform Act
of 1995: Any statements set forth above that are not historical facts are
forward-looking statements that involve risks and uncertainties that could
cause actual results to differ materially from those in the forward-looking
statements. Such factors include, but are not limited to, the Company's
ability to market existing and new products, ability to access to capital for
expansion, and changes from anticipated levels of sales, future national or
regional economic and competitive conditions, changes in relationships with
customers, dependence on its flagship product profits and other factors
detailed from time to time in the Company's filings with the United States
Securities and Exchange Commission and other regulatory authorities. The
Company undertakes no obligation to publicly update or revise any
forward-looking statements, whether as a result of new information, future
events or otherwise.
For more information, please contact:
CCG Elite Investor Relations
Crocker Coulson, President
Tel: +1-646-213-1915 (New York)
Email: crocker.coulson@ccgir.com
Web: http://www.ccgelite.com
SOURCE China-Biotics, Inc.
CCG Elite Investor Relations - Crocker Coulson, President, +1- 646-213-1915
(New York), or crocker.coulson@ccgir.com
